Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Change in Receivables: 2020-2025

Historic Change in Receivables for Caribou Biosciences (CRBU) over the last 5 years, with Sep 2025 value amounting to $171,000.

  • Caribou Biosciences' Change in Receivables rose 471.74% to $171,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $122,000, marking a year-over-year increase of 108.34%. This contributed to the annual value of -$458,000 for FY2024, which is 745.07% down from last year.
  • Latest data reveals that Caribou Biosciences reported Change in Receivables of $171,000 as of Q3 2025, which was up 1,105.88% from -$17,000 recorded in Q2 2025.
  • Caribou Biosciences' Change in Receivables' 5-year high stood at $2.8 million during Q2 2021, with a 5-year trough of -$2.2 million in Q3 2021.
  • In the last 3 years, Caribou Biosciences' Change in Receivables had a median value of -$17,000 in 2025 and averaged -$37,273.
  • As far as peak fluctuations go, Caribou Biosciences' Change in Receivables slumped by 684.47% in 2021, and later skyrocketed by 517.97% in 2023.
  • Caribou Biosciences' Change in Receivables (Quarterly) stood at $127,000 in 2021, then slumped by 481.89% to -$485,000 in 2022, then slumped by 77.32% to -$860,000 in 2023, then soared by 116.86% to $145,000 in 2024, then skyrocketed by 471.74% to $171,000 in 2025.
  • Its last three reported values are $171,000 in Q3 2025, -$17,000 for Q2 2025, and -$177,000 during Q1 2025.